Mike Enzi

It doesn't just bite off small business and solve some small business problems.

One of the biggest concerns for me, as I travel Wyoming and other parts of the country, is that we have given people the impression that with this Health Care Reform that they're not only going to have their costs go down.

I've always concluded that that would be passed on to the workers.

The approach reflected in the current health reform bills is the wrong answer.

And our attempt is to make sure that the companies are not gaming the system at the same time.

I happen to be one who believes strongly in the defined benefit pension program.

I am dismayed to find now that after 3 years, that the bill we passed actually has propelled us more toward the defined contribution plan rather than defined benefit plan.

These are people that worked hard all their lives.

Taxpayers deserve to know how the Delphi situation is tied to the larger Federal bailout of GM.

Thank you, Mr. Chairman.

We have been talking about this narrower corridor.

The drafters of ERISA back in the 1970s were careful not to have the PBGC give too generous of benefits in plans taken over by the PBGC.

What kind of precedent is this setting for future pension plans that are taken over by the PBGC, and what does it say about the use of taxpayer dollars for the top-up?

The challenge that you are going to have is that, once again, it is a paradigm shift that is going to happen through departments and agencies.

I would challenge the Administration to look throughout the Government at where you could apply these ideas.

I strongly support ending all discrimination based on pre-existing conditions, whatever their cause.

Everyone should be able to get the health care coverage they need.

I believe we need to fundamentally reform the insurance market place and offer new protections to ensure that consumers--including people with pre-existing conditions--can buy affordable, high quality health insurance.

This misguided legislation would, among other things, stifle innovation, compromise the safety of American consumers, and threaten the preeminence of the U.S. medical device industry in the world community.

If this legislation is enacted, the risks of marketing a device will greatly increase.

A high percentage of the lawsuits were brought to get defense costs. They were frivolous suits.

This legislation would supplant the findings of the FDA with those of juries in State courts.

We have one of the most, if not the most, innovative and vibrant medical device industries in the world.

This is not only a detriment to healthcare reform, but it undermines the primary healthcare reform goal of controlling the growth curve.

Which would limit access to innovative medical devices and technologies that can dramatically improve quality of life for aging and ailing veterans.